BTAFF (British American Tobacco) Research & Development: $0 Mil (TTM As of Dec. 2025)


BTAFF British American Tobacco PLC BTAFF
67 GF Score
Price $61.62
GF Value $38.65
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is British American Tobacco Research & Development?

British American Tobacco BTAFF 67 Research & Development is $0 Mil as of Dec. 2025. GuruFocus rates BTAFF with a GF Score™ of 67/100 and a GF Value™ of $38.65 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. British American Tobacco's Research & Development for the six months ended in Dec. 2025 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0 Mil.

British American Tobacco  (OTCPK:BTAFF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

British American Tobacco Research & Development Related Terms

British American Tobacco Research & Development Historical Data

* Premium members only.

The historical data trend for British American Tobacco's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

British American Tobacco Research & Development Chart

British American Tobacco Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 187.50 168.09 229.11 219.98 178.05

British American Tobacco Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BTAFF
67GF Score
British American Tobacco PLC BTAFF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

British American Tobacco Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
British American Tobacco (BTAFF) has a Research & Development of $0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on British American Tobacco and its competitors.
Is British American Tobacco's Research & Development too high?
British American Tobacco's current Research & Development is $0 Mil. Overall, British American Tobacco has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does British American Tobacco's Research & Development compare to PM and MO?
British American Tobacco's Research & Development of $0 Mil can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Tobacco Products company?
A good Research & Development depends on the Tobacco Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on British American Tobacco and its competitors. British American Tobacco's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is British American Tobacco stock overvalued right now?
Based on GuruFocus' analysis, British American Tobacco (BTAFF) is currently considered Significantly Overvalued. The stock's GF Value™ is $38.65, compared to a current price of $61.62 — trading 59.4% above its estimated fair value. The current Research & Development is $0 Mil. British American Tobacco's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For British American Tobacco (BTAFF), the current Research & Development is $0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is British American Tobacco (BTAFF) Overvalued in 2026?

Based on GuruFocus' analysis, British American Tobacco stock appears to be overvalued. The current stock price of $61.62 is trading 59.4% above its estimated GF Value™ of $38.65. GuruFocus considers British American Tobacco to be Significantly Overvalued.

Key valuation signals for BTAFF:

  • Research & Development: $0 Mil
  • GF Value™: $38.65 vs. price of $61.62 (59.4% above fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the BTAFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

British American Tobacco Business Description

Address Globe House, 4 Temple Place, London, GBR, WC2R 2PG
The third-largest tobacco company by volume, British American Tobacco sold 465 billion cigarettes in 2025. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.
67GF Score

Get the complete analysis for BTAFF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$61.62
Price
$38.65
GF Value